Clinuvel stock price

Clinuvel Pharmaceuticals Limited is a global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, clinuvel stock price, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. PRENUMBRA is a liquid non-solid injectable formulation of afamelanotide designed to provide a flexible dose of afamelanotide, a synthetic analogue of natural clinuvel stock price stimulating hormone.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies.

Clinuvel stock price

February 24, James Mickleboro. Big returns could be on the cards for owners of these shares according to analysts. February 22, James Mickleboro. February 14, Bronwyn Allen. Will population changes and economic growth in the regions lead to more people buying investment properties there? And is this…. January 24, James Mickleboro. Here are a number of small caps that the broker has given the thumbs up to this week. January 3, James Mickleboro. Analysts think these growth stocks could be good portfolio additions this year. December 8, James Mickleboro. Analysts are tipping big returns for shareholders of these growing companies. November 15, Bronwyn Allen. Market analysts have upgraded their ratings on these four ASX shares today.

Real Time Quote.

Looks you are already a member. Please enter your password to proceed. Forgotten password? Click here. Please make sure your payment details are up to date to continue your membership.

Key events shows relevant news articles on days with large price movements. Clinuvel Pharmaceuticals Limited. CUV 0. UR9 1. Chimerix Inc. CMRX 0.

Clinuvel stock price

Scenesse is the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called EPP and is fairly protected in the near-term from competition. Morningstar brands and products. Investing Ideas. As of Mar 8, am Delayed Price Closed. Unlock our analysis with Morningstar Investor. Start Free Trial. Mar 8, Fair Value. Nov 14, Economic Moat Xcgv.

Lighted magnifying makeup mirror

Analysts are tipping big returns for shareholders of these growing companies. Barron's Archive. Intelligent Investor Membership. January 3, James Mickleboro. Show more Markets link Markets. Income Statement table. Lapsed, 3,01, Rights. Geographically, the company derives the majority of its revenue from its US and European markets. Price To Book Quarterly 4. Fundamentals Data provided by Morningstar.

.

Brenda Mary Shanahan. Memberships Subscribe to Barron's. Barron's Archive. Today's Range Still having trouble viewing content? Registration for this event is available only to Eureka Report members. Fundamentals Data provided by Morningstar. Clinuvel Pharmaceuticals generally pays its shareholder dividend in September. Earnings per share 0. Source: FactSet. Analysts think these growth stocks could be good portfolio additions this year. October 5, James Mickleboro. Having attained the rank of Major General, Dr Rosenfeld is also a former Surgeon General of the Australian Defence Force and remains active in defence and veterans' affairs organisations.